All Blogs

Feb 06, 2019

Relations between the central nervous system and the trillions of bacteria in the gut are being targeted for research. What we know so far is based on studies indicating links between specific gut bacteria, their metabolites and neurological symptoms. However these links do not prove cause and effect. Many studies ...

Feb 05, 2019

FDA discards depression drug ALKS 5461 of Alkermes The FDA has rejected approval for ALKS 5461 of Alkermes in major depressive disorder. ALKS 5461 is a fixed-dose combination of buprenorphine and samidorphan. Alkermes designed the combination to act on the mu- and kappa-opioid receptors that eventually showed im...

Feb 04, 2019

https://www.slideshare.net/DelveInsight/myasthenia-gravis-126250701?qid=b9adbccf-6d91-4e5e-84e1-7603c87a029e&v=&b=&from_search=1 Myasthenia gravis (MG) is an autoimmune syndrome caused by the failure of neuromuscular transmission, which results from the binding of autoantibodies to proteins involved i...

Nov 01, 2024

Neuroendocrine tumors, commonly referred to as NETs, are a complex and often misunderstood type of cancer that can originate in various parts of the body. As with other cancers, these tumors are named based on their site of origin. For example, when NETs develop in the lungs, they are termed lung NETs, which are co...

Jan 31, 2019

Voyager clears Neurocrine agreement for Parkinson's gene therapy Voyager Therapeutics is signing a collaboration agreement with Neurocrine Biosciences that will remunerate the Cambridge, Massachusetts-based biotech USD 165 million upfront. In return, Neurocrine benefits certain rights to four gene therapy progra...

Jan 29, 2019

Biodesix collaborates with MRM for development of mass-spec proteomics Biodesix, the lung cancer diagnostic developer is collaborating with MRM Proteomics to authorize its iMALDI automated assay technology for quantifying proteins using mass spectrometry. It is done with the goal of enabling precision therapies....

Jan 25, 2019

The world's first genetic sequencing of precancerous lung lesions could pave the way for very early detection and new treatments report a new study led by UCL researchers. Before lung cancer develops, precancerous lesions are found in the airway, but only half of these will actually become lung cancer, while others...

Jan 24, 2019

BridgeBio bags USD 299 Million for genetic diseases BridgeBio Pharma has received a USD299.2 million for its progress in genetic disease pipeline. This includes assets in preclinical and clinical development. Several therapeutic areas are being taken under the consideration of the pharma. Also, th...

Jan 23, 2019

The differences between the ‘software’ of humans and monkey brains have been disclosed by neuroscientists for the very first time using a technique that tracks single neurons. They found that brains of human compromise robustness for greater efficiency in processing of information. The results might help in explain...

Jan 22, 2019

Stopping breast cancer metastasis by killing tumor cells in their sleep Oncology researchers believed that dormant breast cancer cells are not responsive to chemotherapy. But these inactive cancer cells can be active at any time and cause life-threatening metastases. Scientists at the Fred Hutchinson Cancer Rese...